Ignoring Adolescent Obesity is a Risk for Later Adult Health
Adolescent obesity is concerning given its high prevalence and associations with adverse physical, social, and emotional health consequences in adolescence and later in life. It also poses a considerable financial burden on the healthcare system as ~ 70% of adolescents with obesity become adults with obesity. In a randomised, controlled trial of adolescents with obesity, the use of liraglutide (3mg) plus lifestyle therapy led to a significantly greater reduction in the BMI standard-deviation score than placebo plus lifestyle therapy.
Modern Medicine – Issue 3 2022
